Drug Information Analysis Service

Reed MD Bertino JS Aronoff SC Speck WT Blumer JL . Evaluation of moxalactam. Clin Pharm 1982; 1: 124–34.

Weitekamp MR Aber RC . Prolonged bleeding times and bleeding diathesis associated with moxalactam administration. JAMA 1983; 149: 69–71.

Pakter RL Russell TR Mielke H West D . Coagulopathy associated with the use of moxalactam (letter). JAMA 1982; 248: 1100.

Holt RJ Gorrochategui M Perez C . Hypoprothrombinemia associated with moxalactam treatment of a septic sternoclavicular arthritis due to citrobacter diversus. Drug Intell Clin Pharm 1981; 15: 288–9.

Lee S Spira S Gabor EP . Coagulopathy associated with moxalactam. JAMA 1983; 249: 2019–20.

Schentag JJ Wels PB Reitberg DP Walczak P Van Tyle JH Lascola RJ . A randomized clinical trial of moxalactam alone versus tobramycin plus clindamycin in abdominal sepsis. Ann Surg 1983; 198: 35–42.

Bang NU Tessler SS Heidenreich RO Marks CA Mattler LE . Effects of moxalactam on blood coagulation and platelet function. Rev Infect Dis (suppl) 1982; 4: S546–54.

Natelson EA Brown CH Bradshaw MW Alfey CP Williams TW . Influence of cephalosporin antibiotics on blood coagulation and platelet function. Antimicrob Agents Chemother 1976; 9: 91–3.

Custer GM Briggs BR Smith RE . Effect of cefamandole nafate on blood coagulation and platelet function. Antimicrob Agents Chemother 1979; 16: 869–71.

Rymer W Greenlaw CW . Hypoprothrombinemia associated with cefamandole. Drug Intell Clin Pharm 1980; 14: 780–3.

Pineo GF Gallus AS Hirsh J . Unexpected vitamin K deficiency in hospitalized patients. Can Med Assoc J 1973; 109: 880–4.

Andriole VT . Pharmacokinetics of cephalosporins in patients with normal or reduced renal function. J Infect Dis 1978; 137: 588–97.

Mortimer PR MacKie DB Haynes S . Ampicillin in human bile in the presence of biliary tract disease. Br Med J 1969; 3: 88–9.

Ratzan KR Baker HB Lauredo I . Excretion of cefamandole, cefazolin and cephalothin into T-tube bile. Antimicrob Agents Chemother 1978; 13: 985–7.

Fujimo R . Laboratory and clinical study on cefoxitin in the surgical field. Chemotherapy 1978; 26: 447–52.

Shimizu K . Absorption, excretion, distribution and metabolism of cefoperazone. Presented at First International Symposium on Cefoperazone Sodium (T-1551), Boston, June, 1979.

Brown CH III Natelson EA Bradshaw MW Williams TW Alfrey CP . The hemostatic defect produced by carbenicillin. N Engl J Med 1974; 291: 265–10.

Haburchak DR Head DR Everett ED . Postoperative hemorrhage associated with carbenicillin administration: Report of two cases and review of the literature. Am J Surg 1977; 134: 630–4.

Karchmer AW Ellman L . Petechiae due to drug-induced platelet dysfunction (letter). N Engl J Med 1976; 295: 451.

Lederer DA Davies T Connell G Davies JA McNicol GP . The effect of carbenicillin on the haemostatic mechanism. J Pharm Pharmacol 1973; 25: 876–80.

Lurie A Ogilvie M Townsend R Carbenicillin induced coagulopathy. Lancet 1970; 1: 1114–5.

Lurie A Ogilvie M Gold CH Meyer AM Goldberg B . Carbenicillin induced coagulopathy (letter). S Afr Med J 1974; 48: 457.

McClure PD Casserly JG Monsier C Crozier D . Carbenicillin induced bleeding disorder. Lancet 1970; 2: 1307–8.

Waisbren BA Evani SB Ziebert AP . Carbenicillin and bleeding (letter). JAMA 1971; 217: 1243.

Woodruff RK Bell WR Castaldi PA . Carbenicillin danger (letter). Med J Aust 1976; 1: 278.

Andrassy K Ritz E Hasper B Penicillin induced coagulation disorder. Lancet 1976; 2: 1039–41.

Brown CH III Natelson EA Bradshaw MW Alrey CP Williams TW . Defective platelet function following the administration of penicillin compounds. Blood 1976; 47: 949–56.

Brown CH III Bradshaw MW Natelson EA Alfrey CP Williams TW . Study of the effects of ticarcillin on blood coagulation and platelet function. Antimicrob Agents Chemother 1975; 7: 652–7.

Natelson EA Siebert WT Williams TW Bradshaw MW . Combined effects of ticarcillin and cefazolin on blood coagulation and platelet function. Am J Med Sci 1980; 278: 217–21.

Alexander DP Russo ME Fohrman DE Rothstein G . Nafcillin induced platelet dysfunction and bleeding. Antimicrob Agents Chemother 1983; 23: 59–62.

Gentry LO Jemsek JG Natelson EA . Effects of sodium piperacillin on platelet function in normal volunteers. Antimicrob Agents Chemother 1981; 19: 532–3.

Jimenez RAH Willkens RF . Dimethylsulfoxide: A perspective of its use in rheumatoid disease. J Lab Clin Med 1982; 100: 489–500.

Muther RS Bennett WM . Effects of dimethylsulfoxide on renal function in man. JAMA 1980; 244: 2081–3.

Bennett WM Muther RS . Lack of nephrotoxicity of intravenous dimethylsulfoxide. Clin Toxicol 1981; 18: 615–8.

Runckel DN Swanson JR . Effect of dimethylsulfoxide on serum osmolality. Clin Chem 1980; 26: 1745–7.

Yellowlees P Greenfield C McIntyre N . Dimethylsulphoxide-induced toxicity (letter). Lancet 1980; 2: 1004–6.

O'Donnell JR Burnett AK Sheehan T Tansey P McDonald GA . Safety of dimethylsulphoxide (letter). Lancet 1981; 1: 498.

Meehan RT Zavala DC . The pathophysiology of acute high-altitude illness. Am J Med 1982; 73: 395–403.

Birmingham Mountain Sickness Study Group. Acetazolamide in control of acute mountain sickness. Lancet 1981; 1: 180–3.

Hackett PH Rennie D Levine HD . The incidence, importance and prophylaxis of acute mountain sickness. Lancet 1976; 2: 1149–54.

Crapo JD . Physical, chemical and aspiration injuries. In: Wynagaarden JB Smith LH , eds. Cecil's textbook of medicine, 16th ed. Philadelphia:WB Saunders Co., 1982: 406–7.

West JB . Respiration in unusual environments. In: Brobeck JR , ed. Best and Taylor's physiological basis of medical practice, 10th ed. Baltimore:Williams & Wilkins, 1979: 6–74–6–78.

Larson EB Roach RC Schoene RB Hornbein TF . Acute mountain sickness and acetazolamide: Clinical efficacy and effect on ventilation. JAMA 1982; 248: 328–32.

Acetazolamide for acute mountain sickness. FDA Drug Bull 1983; 13 (3) 27.